表纸
市场调查报告书

膀胱癌:全球临床实验趋势

Bladder Cancer Global Clinical Trials Review, H2, 2018

出版商 GlobalData 商品编码 212840
出版日期 内容资讯 英文 810 Pages
订单完成后即时交付
价格
Back to Top
膀胱癌:全球临床实验趋势 Bladder Cancer Global Clinical Trials Review, H2, 2018
出版日期: 2018年11月30日内容资讯: 英文 810 Pages
简介

本报告提供全球膀胱癌治疗药的临床试验资料,提供您各国的趋势,临床试验数,潜力治疗药物,及主要企业和研究机关的临床试验状况。

目录

简介

  • 膀胱癌
  • 报告指南

临床试验 各地区

  • 临床试验 各国
    • 对临床实验有所贡献的前五国 - 亚太地区
    • 对临床实验有所贡献的前五国 - 欧洲
    • 对临床实验有所贡献的前几名国家 - 北美
    • 对临床实验有所贡献的前几名国家 - 中东及非洲
    • 对临床实验有所贡献的前几名国家 - 中南美

临床试验:G7 各国

临床试验:G7 各国 各临床实验状态

临床试验:E7 各国

临床试验:E7 各国 各临床实验状态

临床试验 各Phase

  • 进行中的临床实验 各Phase

临床试验 各临床实验状态

未完成的临床实验

每段时期的实验人数

有力的赞助商

参与临床实验的主要企业

潜力治疗药物

临床试验 简介

  • 临床试验概要: 前几名企业
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Pfizer Inc.
    • Spectrum Pharmaceuticals, Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Endo Health Solutions Inc.
    • Bristol-Myers Squibb Company
  • 临床试验概要: 最高级大学 / 研究机关 / 医院
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • European Organization for Research and Treatment of Cancer
    • The University of Texas M. D. Anderson Cancer Center
    • National Bladder Cancer Collaborative Group
    • Southwest Oncology Group
    • Medical Research Council Clinical Trials Unit
    • University of Michigan
    • Eastern Cooperative Oncology Group
    • Medical Research Council

5个主要的临床试验简介

附录

图表一览

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC5483CTIDB

GlobalData's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy:

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
    • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*

List of Figures

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • GlobalData Methodology
Back to Top